← Banking With Billy News

$HRTX: +589.7% potential upside ($0.29 to $2, single H.C. Wainwright target). Acute Care growth helps, but CINVANTI patent risk and debt keep this speculative.

BWB News TV • 2026-11-09 11:50 UTC • By Billy Odell Tucker-Robinson
$HRTX: +589.7% potential upside ($0.29 to $2, single H.C. Wainwright target). Acute Care growth helps, but CINVANTI patent risk and debt keep this speculative.
$HRTX: +589.7% potential upside ($0.29 to $2, single H.C. Wainwright target). Acute Care growth helps, but CINVANTI patent risk and debt keep this speculative. Target, not a promise. #Biotech #PriceTarget
Share this article
𝕏 X / Twitter Facebook LinkedIn WhatsApp
📚 More from Billy’s World
📰 Banking With Billy News All breaking financial news & market analysis 📚 Banking With Billy Books Deep-dive books on every financial story 💬 Join the Community discord.gg/VHxwmR5j4Y 🎥 Banking With Billy on YouTube Live streams & market commentary

Banking With Billy News Network — bankingwithbilly.com
Discord: discord.gg/VHxwmR5j4Y • YouTube: @BankingWithBilly